Evidence map›Paper›PMID 40347046›Full record

ArticleDrug and alcohol review2025

Disparities in Opioid Agonist Treatment Accessibility for Priority Populations in New South Wales, Australia.

James H Conigrave, Timothy Dobbins, Nicholas A Buckley, K S Kylie Lee, Kirsten C Morley, Michael Doyle, Basma Al-Ansari, Scott Wilson, Summer Loggins, Katherine Conigrave

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug and alcohol review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

James H ConigraveCentre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.ORCID 0000-0002-8816-6229
Timothy DobbinsSchool of Population Health, University of New South Wales, Sydney, Australia.
Nicholas A BuckleyFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, Australia.
K S Kylie LeeCentre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.ORCID 0000-0001-5410-9464
Kirsten C MorleyFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, Australia.ORCID 0000-0002-0868-9928
Michael DoyleFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, Australia.ORCID 0000-0003-2083-8575
Basma Al-AnsariCentre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.
Scott WilsonCentre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.
Summer LogginsCentre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.
Katherine ConigraveFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, Australia.ORCID 0000-0002-6428-1441

Funding

NSW Health
6 · The paper itself

Abstract

introductionOpioid agonist treatment (OAT) is effective for managing opioid dependence; however, it can be hard to access in some regions. We investigated OAT access for priority populations living in New South Wales, Australia: Aboriginal and Torres Strait Islander peoples, Culturally and Linguistically Diverse (CALD) peoples, and youth (18-24 years).

methodUsing a linked database, we analysed distances between residential postcodes and OAT dosing points for 29,935 individuals from July 2015 to June 2020. We used multi-level models with random intercepts for clients to assess the relative distance lived from dosing points for members of each priority population.

resultsThe median distance to dosing points was 9.80 km. Multi-level regression predicting log-transformed distance (ln) showed, relative to others, Aboriginal and Torres Strait Islander clients lived 89.98% (95% confidence interval [CI] 82.25%, 98.04%) further, and youth lived 15.09% (95% CI 4.70%, 26.52%) further from dosing points. In contrast, CALD individuals lived 35.32% (95% CI 31.88%, 38.58%) closer than others. Multi-level logistic regression showed Aboriginal and Torres Strait Islander clients were 3.39 (95% CI 2.82, 4.07) times more likely to live 50 km or more from their chosen dosing point. DISCUSSION AND

conclusionAboriginal and Torres Strait Islander Australians and youth have poorer access to OAT dosing points than others in New South Wales. CALD individuals live closer to dosing points, which could suggest better access, or reticence to travel far for care. Targeted interventions are needed to improve OAT accessibility in regional and remote areas.

Indexed as

Analgesics, OpioidHealthcare DisparitiesHealth Services AccessibilityOpiate Substitution TreatmentOpioid-Related DisordersAdolescentAustralian Aboriginal and Torres Strait Islander PeoplesFemaleHumansMaleNew South WalesYoung AdultAnalgesics, Opioidcultural diversityhealth services accessibilityIndigenous peoplesopioid substitution treatmentyoung adult

Identifiers

PMID40347046
PMCPMC12117287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.